The suit claims Aetna's policy violates the anti-discrimination provisions of the Patient Protection and ACA and city and state human rights laws in New York.
The suit alleges McKesson and its subsidiaries extracted the overfill from oncology drugs, repacked it and distributed it to medical providers who then applied with the government for reimbursement.